Johansson Catharina, Tengvall Linder Maria, Aalberse Rob C, Scheynius Annika
Department of Medicine, Unit of Clinical Allergy Research, Karolinska Institute and Hospital, Stockholm, Sweden.
Int Arch Allergy Immunol. 2004 Oct;135(2):93-100. doi: 10.1159/000080651. Epub 2004 Sep 2.
The opportunistic yeast Malassezia is considered to be one of the factors that can contribute to atopic eczema (AE). Elevated serum IgE levels, T-cell proliferation and positive skin prick test (SPT) and atopy patch test (APT) reactions to Malassezia are found among AE patients.
Sera from 127 AE patients, 14 patients with seborrheic dermatitis (SD) and 33 healthy controls were investigated for IgE and IgG4 to M. sympodialis extract and four recombinant Malassezia allergens; rMala s 1, rMala s 5, rMala s 6, and rMala s 9. In addition, IgG to the recombinant allergens was analyzed. The IgG and IgG4 levels were compared to IgE levels and in vivo reactions (SPT and APT) to Malassezia.
AE patients with serum IgE levels >0.35 kU/l to M. sympodialis extract had significantly higher IgG4 levels to M. sympodialis extract than AE patients without detectable serum IgE to M. sympodialis extract, SD patients and healthy controls. Among the AE patients with and without detectable serum IgE to M. sympodialis extract, respectively, there were no differences in IgG4 levels between patients with positive or negative in vivo reactions to M. sympodialis extract. IgG4 to the rMala s allergens was almost exclusively found among patients with IgE to the same allergen. Within the four tested rMala s allergens, most IgG4 reactions were found to rMala s 6, an allergen with homology to cyclophilin.
Elevated serum IgG4 to M. sympodialis extract accompanies elevated serum IgE to the extract. This is further confirmed by the association between IgG/IgG4 and IgE to recombinant Malassezia allergens.
机会性酵母马拉色菌被认为是导致特应性皮炎(AE)的因素之一。在AE患者中发现血清IgE水平升高、T细胞增殖以及对马拉色菌的皮肤点刺试验(SPT)和特应性斑贴试验(APT)呈阳性反应。
对127例AE患者、14例脂溢性皮炎(SD)患者和33名健康对照者的血清进行检测,分析其针对合轴马拉色菌提取物和四种重组马拉色菌变应原(rMala s 1、rMala s 5、rMala s 6和rMala s 9)的IgE和IgG4水平。此外,还分析了针对重组变应原的IgG水平。将IgG和IgG4水平与IgE水平以及对马拉色菌的体内反应(SPT和APT)进行比较。
血清IgE水平>0.35 kU/l针对合轴马拉色菌提取物的AE患者,其针对合轴马拉色菌提取物的IgG4水平显著高于血清中未检测到针对合轴马拉色菌提取物IgE的AE患者、SD患者和健康对照者。在血清中可检测到和未检测到针对合轴马拉色菌提取物IgE的AE患者中,针对合轴马拉色菌提取物体内反应阳性或阴性的患者之间IgG4水平无差异。针对rMala s变应原的IgG4几乎仅在对相同变应原有IgE的患者中发现。在四种测试的rMala s变应原中,大多数IgG4反应针对rMala s 6,这是一种与亲环蛋白具有同源性的变应原。
血清中针对合轴马拉色菌提取物的IgG4升高与针对该提取物的血清IgE升高相伴。IgG/IgG4与针对重组马拉色菌变应原的IgE之间的关联进一步证实了这一点。